Sher Bahadur (Research Associate)
Sher was born and raised in Rawalpindi, Pakistan and moved to the United States for his undergraduate studies. He received his BS in Biochemistry and Molecular Biology in 2022 from Dickinson College in Carlisle Pennsylvania. During his time at Dickinson, Sher worked in Dr. Michael Roberts’ lab, investigating gene targets for potential Acute Myeloid Leukemia therapies. For his honors thesis, Sher characterized the role of the MAPK/ERK signaling modulator SPRY2 in regulating the transcriptome of the HL-60 Acute Myeloid Leukemia cell line. In the Bando Lab, Sher contributed to efforts to characterize FGFR alterations in pediatric gliomas, and to develop methods to optimize TP53 reactivation in Diffuse Midline Gliomas. He was accepted into the graduate program at Weill Cornell to complete his PhD in 2024.
Fun fact: In his native language of Urdu, Sher’s full name translates to “lion/tiger brave”. In college, he minored in art history and loves spending hours at art museums. Sher also loves watching European football and is a die-hard Chelsea football club fan.
Olivia Blumenshine (Research Associate)
Olivia received her B.A. in English and Anthropology from Washington University in St. Louis (’22). Olivia worked in two labs during her time at WashU: Dr. Natalie Mueller’s paleoethnobotany lab where she analyzed plant samples from Late Archaic food sites in modern-day Mississippi, and Dr. Crickette Sanz’s Digital Lab for Primatology where she studied captive and wild chimpanzee ecology and ontogeny. In the Bandopadhayay Lab, Olivia worked to understand the mechanisms through which histone mutations induce gliomagenesis, and to develop strategies to enhance efficacy of targeted inhibitors for pediatric low-grade gliomas.
Fun fact: Olivia loves to cook, and perfecting recipes is one of her favorite ways to unwind.
Adam Boynton (Postdoctoral Fellow)
Adam received his BS with honors in chemistry from Trinity College (’12), where he worked in the lab of Dr. Tim Curran exploring the coordination of tungsten to diphenylacetylene ß-turn peptidomimetics. He then pursued a PhD in chemistry at Caltech (’17) under the mentorship of Dr. Jackie Barton. While at Caltech, Adam studied luminescent ruthenium complexes that function as “light switch” probes for DNA mismatches. In the Bando Lab, he applied approaches to therapeutically target cancers that harbor mutations in the Mismatch Repair pathway. He also contributed to efforts to characterize chromatin complexes as therapeutic targets for pediatric brain tumors. Adam joined the team at Kronos Bio in 2023 where he is excited to contribute to efforts focused on on target discovery and drug development.
Fun fact: Adam’s passions expand beyond the lab and include weightlifting, hot yoga, singing acappella, heading to the ballpark for a game, and visiting craft breweries.
Graham Buchan (Research Associate)
Graham received his BA with honors in biology from Williams College. As an undergraduate researcher, Graham studied the genetic link between dopamine signaling and arousal state in Drosophila. Graham was also the varsity captain of the Williams College men’s crew rowing team. In the Bandopadhayay Lab, Graham characterized the mechanism through which fusion proteins contribute to the formation of pediatric low-grade gliomas. He also made significant contributions to elucidating the role of PPM1D mutations in driving growth of Diffuse Intrinsic Pontine Gliomas. Graham is currently a medical student within the Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine.
Seung Hyun ‘Riley’ Choi (Research Associate)
Riley was born and raised in Seoul, South Korea, and moved to the U.S when she was 11 years old. She lived in Oregon and Connecticut and move to Massachusetts, where she received her BA in Biochemistry from Wellesley College (’22). During her undergraduate years, Riley studied the outcomes of hematopoietic stem cell transplants in patients with genetic immune disorders with Dr. Jennifer Whangbo and Dr. Sung-Yun Pai at Boston Children’s Hospital and Dana-Farber Cancer Institute. Riley contributed to efforts to understand genetic and epigenetic mechanisms of resistance in brain tumors, focusing on resistance to BET-bromodomain inhibitors and vulnerabilities induced by loss of mismatch repair proteins. She was accepted to UPenn in 2024 to commence her medical studies.
Fun fact: Riley chose her English name when she moved to the U.S because it means ‘courage’. During her free time, Riley enjoys watching documentaries, cooking Korean food, and visiting cafes to drink iced vanilla latte.
Marissa Coppola (Research Associate)
Marissa received her BS in Biochemistry and Molecular Biology from UMass Amherst in 2022. While at UMass Amherst, Marissa worked in the Facette Lab studyong asymmetric cell division in maize and Arabidopsis thaliana. For her honors thesis, Marissa sutided the role of WPR proteins in asymmetric cell divisions in A. thaliana roots. In the Bandopadhay Lab, Marissa helped study drivers of Diffuse Midline Gliomas, including the mechanisms through which MYC isoforms are activated. She also contributed to efforts to understand how the FOXR2 transcription factors enhances formation of tumors across pediatric and adult cancers, including in pediatric brain tumors. Marissa moved to LA in 2024 as the first member of Jess Tsai’s new lab at Children’s Hospital Los Angeles.
Fun fact: In her free time, Marissa loves to go on bike rides, do yoga and walk her dog. She also loves bagels and is always on the hunt for the best bagel.
Madison ‘Maddie’ Chacon (Research Associate)
Maddie received her MS and BS in Biology from Brandeis University in 2021. During her time at Brandeis, Maddie worked in the lab of Sebastian Kadener studying RNA metabolism and the circadian rhythm. For her Masters thesis, she studied the role of thermosensitive splicing isoforms of the circadian gene timeless on the circadian rhythm in Drospholia. In the Bandopadhayay Lab, Maddie worked on efforts to identify resistance mechanisms in pediatric brain tumors. She received a Fulbright Award to extend her studies in Germany, before starting graduate school at UCLA.
Fun fact: Maddie is a multimedia artist and during quarantine, Maddie collaged all of the wooden furniture in her apartment.
Jessica ‘Jess’ Clymer (Affiliated Instructor)
Jess was born in Seattle, WA but spent most of her childhood just (2 hours) down the road in Pittsfield, MA. She received her BS in 2007 from the University of Michigan and her medical degree from the Ohio State University in 2011 and stayed in Columbus OH to complete her pediatric residency training. In 2014, she traveled north to Chicago for her Pediatric Hematology/Oncology fellowship before moving to Boston in 2017 to complete subspecialty training in Pediatric Neuro-Oncology at the Dana-Farber/Boston Children’s Cancer and Blood Disorder Center. Jess joined the Pediatric Neuro-Oncology Faculty in 2018. Her research interest is in medulloblastoma and early phase clinical trial development. Jess worked with the Bandopadhayay Lab to validate dependencies and resistance mechanisms in medulloblastoma.
Fun fact: during her 4th year of medical school, Jess cycled from San Diego to Washington DC with Ride for World Health; she loves to travel with her most recent adventures being to Morocco and Argentina; she has an adorable cat, Sassafras, who is not a fan of Jess traveling.
Alexandra ‘Larisa’ Condurat (Postdoctoral Fellow)
Larisa received her B.Sc. degree in experimental biology from the University of Bucharest-Romania in 2011, where she investigated the importance of specific nucleotide polymorphisms in breast cancer patients. During her B.Sc studies, she did an Erasmus exchange semester at the University Paris Diderot. In 2013, she obtained her M.Sc degree in cancer biology, with a focus on oncolytic virotherapy of cancer, from the University of Heidelberg and the German Cancer Research Center (DKFZ). Larisa earned her PhD in 2018 from the Freiburg University in Germany, where she investigated the role of the Hippo/YAP-TAZ signaling pathway in neural crest development and neuroblastoma progression under the mentorship of Dr. Jan Pruszak. In the Bandopadhayay lab, Larisa worked on projects to improve treatments for children with gliomas. Her projects included the development of therapeutic strategies for fusion proteins in pediatric low-grade gliomas, and the landscaping of transcriptional profiles of pediatric gliomas at the single cell level. Larissa is currently working in the Netherlands to gain experience in the use of CAR T-Cells as cancer therapeutics.
Jeromy Digiacomo (Research Associate)
Jeromy studied chemistry, public health, and Spanish at Williams College. During his senior year, he completed an honors chemistry thesis characterizing the substrate specificity of phosphopantetheinyl transferase enzymes in Streptomyces avermitilis under the instruction of Dr. Amy Gehring. In the Bandopadhayay Lab, Jeromy studied pediatric brain tumors that are caused by alterations in FGFR proteins, in addition to other driver alterations. He is currently a MD-PhD student at UMass.
Fun fact: During college, Jeromy was part of the Williams College’s Zambezi Marimba Band. The band performs both traditional and western music on the world’s only chromatically tuned Zimbabwean-style marimbas. In his spare time, Jeromy likes writing music and playing Animal Crossing on his Nintendo Switch.
Jeyna Doshi (Undergraduate Student)
Jeyna graduated from Harvard College in 2020. She worked with the Bando Lab over several semesters and summers as an undergraduate student, receiving numerous fellowships to support her work. During her undergraduate studies, Jeyna focused on Integrative Biology and was involved various clubs on campus. One such club is Camp Kesem, an organization for children whose parents have cancer. She was also a trip leader for the Harvard Outing Club and a member of the club soccer team. In her free time, Jeyna loves to cook, bake, read, ski, and be outside as much as possible. In the Bandopadhayay Lab, Jeyna worked to identify novel therapeutic strategies for children with MYB and MYBL1 altered tumors.
Yohanna Georgis (Undergraduate student)
Yohanna worked in the Bandopadhayay Lab as a high school and then undergraduate student (Tufts University). She contributed to efforts to study PPM1D as a therapeutic target for DIPG. She was specifically interested in the effects of a truncating mutation in PPM1D as a contributor to cellular resistance to treatment, and in determining if this mutation in PPM1D is oncogenic in DIPG.
Fun fact: Yohanna and Beyoncé share a birthday.
Gabrielle ‘Gabi’ Gionet (Research Associate)
Gabi is a Denver native, and recent Boston transplant. So far, she is enjoying kayaking on the Charles River and cheering on the Bruins hockey team. Gabi graduated from McGill University as a double major in Molecular Biology and English. In the Bandopadhayay Lab, Gabi worked to identify molecular dependencies in medulloblastoma. She hopes this work could lead to a cancer treatment which can be made financially accessible to sick children around the world. Gabi commenced her Graduate Studies at Boston University in 2020, and was accepted into multiple programs to commence her PhD studies in 2023.
Fun fact: Gabi has correctly spelled the word ‘fluorescent’ three times in her life.
Elizabeth ‘Eli’ Gonzalez (Research Associate)
Eli majored in molecular and cell biology at the University of Pennsylvania and is originally from Miami, Florida. She aspires to be a physician scientist and join the efforts to discover better treatments for rare pediatric cancers. As a research assistant in the Bandopadhayay Lab, Eli developed strategies to uncover genomic dependencies of pediatric brain tumors. She is also interested in science diplomacy, particularly collaborations on cancer research between the US and Cuba. Eli commenced her MD-PhD studies at UPenn in 2020.
Fun fact: Eli loves to snorkel, and her favorite animal is a Yellowtail Damselfish.
Tricia Ho (Research Associate)
Tricia received her BA from Williams College, where she majored in biology and music. For her undergraduate thesis, she studied the effect of sublingual immunotherapy on lung tissue-resident T cells in allergic asthma. In the Bando lab, Tricia studied mechanisms of drug resistance in pediatric brain tumors. She is currently a MD-PhD student at Columbia University.
Fun fact: Tricia plays cello and piano. Fun musical moments have included a play where she was stranded alone with her cello on a stairless platform for three hours, an orchestra rehearsal briefly attended by Sting, and a wedding proposal at the top of a hill that almost happened until bad weather occurred.
Spandana Jarmale (Undergraduate student)
Spandana was a Junior at Brown University studying Neuroscience when she joined the Bandopadhayay Lab, having spent the previous year researching biomarkers of Alzheimer’s and its presentation in patients. She is interested in the transition of the brain from healthy to pathological and hopes to apply this to understand how pediatric brain tumors develop. Spandana completed a Summer Fellowship with the Bandopadhayay Lab during which time she studied therapeutic approaches for Diffuse Intrinsic Pontine Gliomas.
John Jeang (Computational Scientist)
John spent his entire life in Rockville, MD until college when he moved to Claremont, CA to earn his B.S. in Physics. For his senior clinic project, John worked with HRL Laboratories to create an algorithm for electrostatically tuning quantum dots using neural networks for quantum computers. Before joining the Bando Lab, John worked as a High Frequency Trader. In the Bando Lab, he was excited to use his skills to contribute to cancer research, specifically focusing on improving our understanding of childhood brain tumors and the development of more effective treatments. John started his PhD at the University of Tufts in 2024.
Fun fact: Almost all of John’s socks are Christmas themed!
Danny Jomaa (Graduate Student)
Danny received his BSc in Physiology and Psychology from McGill University and his MSc in Biochemistry from the University of Ottawa, where he used CRISRP to knock out genes involved in glioblastoma invasion. Danny recently deferred his medical studies to come to Boston to complete his Master of Biomedical Informatics program at Harvard University in the Bandopadhayay Lab. In the Bando Lab, Danny applied computational approaches to characterize the genetic landscape of pediatric brain tumors. Danny hopes to pursue a career as a clinician-scientist, combining his clinical interests in pediatrics with his research interests in cancer and genetics. After completing his Masters, he returned to Queen’s University in Canada to complete his final year of medical school.
Fun fact: Danny is an avid baker, restaurant-goer, and cafe-hopper. He is excited for the food scene in Boston and is always looking for recommendations!
Prasidda Khadka (Graduate Student)
Prasidda received his BA in biology and biochemistry from Carleton College in Northfield, Minnesota, before joining the BBS PhD program at Harvard University in 2016. In the Bandopadhayay Lab, Prasidda studied the role of PPM1D mutations in the pathogenesis of Diffuse Intrinsic Pontine Glioma (DIPG), in addition to spearheading efforts to further characterize the genomic landscape of pediatric craniopharyngiomas. Prasidda defended his PhD in 2021, before heading to medical school at UCLA.
Rushil Kumbhani (Research Associate)
Rushil was born and raised in Central New Jersey, and moved to Providence, RI where he received his BS in Biology from Brown University in 2020. Throughout his undergraduate studies, Rushil worked in Dr. Richard Bennett’s lab studying mechanims underlying white-gray-opaque phenotypic switching in the human fungal pathogen, Candida albicans. For his senior honors thesis, Rushil quantified gray-opaque phenotypic switching frequencies in transcription factor knockout backgrounds to characterize master regulators of switching. In the Bandopadhayay Lab, Rushinl studied how certian genes confer resistance to BET-bromodomain inhibitors in MYC-amplified medulloblastomas. In a second project, Rushil also worked identify synthetic lethalities associated with loss of MMR-proteins in high-grade gliomas and DIPGs, with the goal of leveraging these in potential therapeutic strategies. Rushil is currently a medical student at Zucker School of Medicine at Hofstra.
Fun fact: In college, Rushil was a member of the South Asian fusion dance team, Badmaash, which showcases styles like Bhangra, Bollywood, and Hip Hop. Rushil is also an avid coffee drinker, and spends many mornings trying to make the perfect cold brew.
Leslie Lupien (Postdoctoral Fellow)
Leslie received her BA in Biological Sciences from Assumption College in 2010, before moving on to complete her PhD in the Program in Experimental and Molecular Medicine at Dartmouth College. In the lab of Dr. William Kinlaw, Leslie studied lipid metabolism in breast cancer cells. Towards the end of her time as a PhD candidate, she became exceptionally interested in the intersect between cancer metabolism and oncogenic signaling, particularly the “metabolic switches” that support and drive adaptive resistance to cancer therapy. In the Bandopadhayay Lab, Leslie worked able to combine her background in cancer cell metabolism with genomic, transcriptomic and gene editing approaches to understand the biology of pediatric brain tumors and elucidate mechanisms of resistance to targeted therapies such as BET-bromodomain inhibition. She also evaluated the role of altered metabolic signaling to driving formation of pediatric tumors such as Diffuse Intrinsic Pontine Gliomas.
Fun fact: Leslie played basketball through college and is now an avid cyclist. She also enjoys amateur photography.
Sophie Lu (Research Associate)
Sophie studied Biology and Statistics at Williams College, completing an honors thesis on the application of Bayesian statistics in the context of ecological methodology. She was born and raised in Gilbert, Arizona, and loves to paint and cook. In the Bando Lab, Sophie studied mechanisms through which PPM1D mutations drive DIPG formation, and contributed to efforts to characterize the genomic landscape of pediatric craniopharyngiomas. She started her graduate studies at George Washington University in 2021, completing her Masters in 2023. Sophie started her studies as medical student at the Cleveland Clinic Lerner College of Medicine, Case Western Reserve University School of Medicine in 2023.
Fun fact: Sophie cannot remember any song lyrics beyond the song title – other than Happy Birthday or Twinkle Twinkle….
Jens Maile (Graduate Student)
Jens received his BS in Molecular Medicine from the University of Tubingen Germany in 2021, where he studied synthetic lethal interactors of mTOR inhibition in glioblastoma in the labs of Prof. Ghazaleh Tabatabai and Dr. Daniel Merk. As part of his bachelor’s program, he joined the group of Prof. Tony Kourzarides at the University of Cambridge in 2019 as a visiting undergraduate student to investigate the role and pharmacological inhibition of histone acetyl transferases in leukemia. Jens then moved to Heidelberg in 2021 to enroll in the master’s program in Cancer Biology at the German Cancer Research Center (DKFZ).
Jens joined the Bando Lab in 2023 as a visiting graduate student to understand how distinct histone mutations influence gliomagenesis and also aims to exploit the dependence of pLGGs on the MAPK pathway. Jens is co-mentored by Dr. David Jones at the DKFZ.
Fun fact: One of the first things Jens did when he arrived in Boston was to buy a bike. He also enjoys playing handball and online chess.
Eric Morin (Postdoctoral Fellow)
Eric received his MS in biomedicine from Uppsala University, Sweden in 2010. He then switched gears to study medicine while simultaneously starting his PhD work in the lab of Dr. Lena Claesson-Welsh at Uppsala University. Eric studied how the interaction of cell surface proteins expressed by different cell types can regulate blood vessel formation in normal cells and tumors. Eric received his medical degree in 2016 and defended his PhD thesis in 2018. Eric joined the Bandopadhayay Lab in 2020 where he is working to characterize driver mutations found in pediatric brain tumors and developing new approaches to treat these children with targeted therapies. Eric returned to Sweden in March 2023 to resume his clinical training as he continues on his career path towards becoming a physician-scientist in pediatric oncology.
Fun fact: Like many Swedish people, Eric has completed Vasaloppet, a 60-mile cross-country skiing race (twice!). In his spare time, Eric enjoys any combination of ‘the three Bs’: Boardgames, Beer and Broncos (Denver).
Dana Novikov (Research Associate)
Dana received her BA in Biology from the University of Pennsylvania (’21). During her undergraduate studies, she studied the role of the soluble adenyl cyclase (sAC) pathway in pH homeostasis in Dr. Katie Barott’s lab. Dana joined the Bandopadhayay Lab in 2021 where she worked to apply single-cell methods to evaluate the heterogeneity of pediatric gliomas, and to understand spatial associations. Dana started her medical studies at Temple University in 2023.
Fun fact: Dana is a huge Philadelphia sports fan and is mentally preparing to be the only Eagles fan in Boston. Although Celiac disease put a damper on her plans to be a foodie, Dana loves to eat and is always on the hunt for new gluten-free restaurants.
Lilia Olmstead (Graduate Student)
Lilia was born and raised in El Paso, Texas. She received her Bachelors degree in Cellular and Molecular Biochemistry from the University of Texas in El Paso in 2021. During her time at UT El Paso, she worked on HIV-1 and Flaviviruses in Dr. Mauel Llano’s Lab. Lilia was a MARC Scholar and completed her undergraduate thesis characterizing proteins implicated in viral replication. Lilia is now a Harvard BBS Student. Lilia worked in Bando Lab on projects focused on Atypical Teratoid Rhaboid Tumors, a devastating brain tumor than occurs in infants and young children.
Fun fact: Lilia knows how to play five instruments! These include the flute, violin, guitar, ukulele and the piano. She also enjoys keeping active and going to art museums.
Ryan O’Rourke (Research Associate)
Ryan received a Bachelor of Science in animal science from the University of Vermont in 2014. In the Bandopadhayay Lab, Ryan studied resistance mechanisms in pediatric brain tumors and contributed to efforts to develop novel technologies to track individual lineages of cells throughout treatments. Ryan is currently a graduate student at Brown University.
Kenin ‘Kenny’ Qian (Research Associate)
Kenny received his BA from Northwestern University in Integrated Science and in Biological Sciences. At Northwestern, he completed his honors thesis on genomic editing using CRISPR/Cas9 through gene knock outs, knock ins, and genome wide screens. In the Bandopadhayay Lab, Kenny studied methods to target Glioblastomas that contain alterations in the Mismatch Repair Pathway. Kenny started his MD-PhD studies at UCLA in 2020.
Fun fact: Kenny was bald until the age of 18.
Zach Reitman (Postdoctoral Fellow)
Zach was born in Glenmoore, Pennsylvania (outside Philadelphia). He studied biochemistry and molecular biology at Penn State (’06), and then pursued an MD/PhD at Duke University in Durham, North Carolina (’14). At Duke, Zach earned his PhD under the mentorship of Professor Hai Yan on research in the Tisch Brain Tumor Center revolving around gliomas and cancer-associated mutations in IDH1, TERT, PPM1D, ATRX, and several other very interesting genes. His research aimed at better classifying cancers to select appropriate treatments, and on identifying targets for new therapies for these brain tumors. Zach then spent a year in Baltimore at Union Memorial Hospital doing a preliminary year in internal medicine. He completed his training in radiation oncology in the Harvard Radiation Oncology Program (’19). In the Bandopadhayay lab, Zach studied pediatric low-grade gliomas at a single cell resolution, in addition to determining how PPM1D mutations may be therapeutic targeted in Diffuse Intrinsic Pontine Gliomas. In 2019, Zach accepted a faculty position to initiate his own research program at Duke University Brain Tumor Center. In addition, he will work as an Attending Radiation Oncologist, pursuing his goal of combining research with clinical care to improve outcomes for children and adults diagnosed with brain tumors.
Fun fact: When he is not pipetting or fielding pages, Zach enjoys cycling, hiking, microbrewed beer, and Penn State and Philadelphia Eagles football. He likes spending time with his wife, Denise, baby Jack and their two cats, Wink and Arya.
Jessica ‘Jess’ Tsai (Postdoctoral Fellow)
Jess received her BS in Biological Sciences with Honors in Neurobiology at Stanford University in 2008 before joining the Medical Scientist Training Program at Stanford University School of Medicine, receiving her MD and PhD in 2015. Jess earned her PhD in Neuroscience working in the laboratory of Dr. Thomas Clandinin, utilizing the Drosophila visual system and forward genetics to study synapse development and axon degeneration. She then moved from the Bay Area to Boston where she completed her Pediatrics residency at the Boston Combined Residency Program at Boston Children’s Hospital and Boston Medical Center in 2018, before joining the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center as a Pediatric Hematology/Oncology/Stem Cell Transplant Fellow. In the Bandopadhayay Lab, Jess applied genomic approaches to identify therapeutic targets for pediatric brain tumors.
Jess accepted a position as an Assistant Professor and physician-scientist, and initiated her own independent research laboratory at the Children’s Hospital of Los Angeles in 2024.
Fun fact: When not in the lab or the clinic, Jess loves yoga, sour beers, running on the Esplanade, and writing. She makes a mean pour over coffee, and her favorite animal is a tie between a sloth and a quokka.
Dayle Wang (Research Associate)
Dayle studied biomedical engineering at Dartmouth College, earning a BA and BE dual-degree. Her senior honors thesis examined the dynein-anchoring protein, Num1, and dynein’s mitotic spindle positioning function in Saccharomyces cerevisiae in Dr. Wei-Lih Lee’s laboratory. In the Bandopadhayay Lab, Dayle is working on uncovering novel therapeutic targets for pediatric high-grade gliomas. Her projects included characterization of the role of long non-coding RNAs in the formation of Diffuse Intrinsic Pontine Gliomas, and understanding the contribution of transcription factors to glioma formation. Dayle is currently a MD-PhD student at Vanderbilt University.
Fun fact: Dayle especially enjoys exploring hiking trails and natural parks, spending time with her pets, learning new things, and trying new foods!
Travis Zack (Medical Student)
Raised in Hawaii, Travis completed his undergraduate studies at UC Berkeley, double majoring in Physics and Integrative Biology. He then went on to complete his PhD in the Biophysics program of Harvard University under the mentorship of Dr. Beroukhim, focusing on uncovering new cancer vulnerabilities predicted by copy number alterations using computational genomics. Travis completed his MD thesis in the Bandopadhayay lab, contributing to efforts to characterize the landscape of structural variants in pediatric High-grade Gliomas and Diffuse Intrinsic Pontine Gliomas. Travis hopes to continue to contribute to the field of oncology as a physician-scientist. He completed residency at UCSF after graduating with his MD from the Harvard and MITs Health Sciences Technology Program and is now undergoing fellowship training in hematology and oncology.
Fun fact: In his free time, Travis is an avid hiker and amateur gardener.
Kevin Zhou (Research Associate)
Kevin was born and raised in Seattle, and moved to the east coast to pursue a B.A in biology from Williams College (’20). During his undergraduate, Kevin worked with Dr. Amy Gehring to elucidate regulatory pathways of secondary metabolite biosynthesis in Streptomycetes, culminating with an honors biology thesis characterizing substrate specificities of phosphodiesterases from Streptomyces avermitilis. With the Bandopadhayay Lab, Kevin worked on projects that apply single-cell RNA-sequencing and CRISPR-cas9 methods to characterize pediatric gliomas and to develop better therapeutic strategies for these childhood tumors. Kevin is now a medical student at the Kaiser Permanente Bernard J Tyson School of Medicine.
Fun fact: Kevin loves ice cream, and is still salty about getting rejected as an ice cream scooper the summer before college because his resume was “too diverse and unrelated”. He is also a devout Christian, and regularly turns water into kombucha.